Byron; Peter R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Byron; Peter R..The latest application filed is for "methods and compositions for pulmonary administration of a tnfa inhibitor".

Company Profile

0.9.6

Byron; Peter R. - Richmond VA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions for pulmonary administration of a TNFa inhibitor App 20090110679 - Li; Luk-Chiu ; et al.	2009-04-30
Method and apparatus for generating an aerosol Grant 7,128,067 - Byron , et al. October 31, 2	2006-10-31
Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution Grant 6,883,516 - Hindle , et al. April 26, 2	2005-04-26
Delta9 tetrahydrocannabinol (delta9 THC) solution metered dose inhalers and methods of use App 20040258622 - Peart, Joanne ; et al.	2004-12-23
.DELTA.9 tetrahydrocannabinol (.DELTA.9 THC) solution metered dose inhalers and methods of use Grant 6,713,048 - Peart , et al. March 30, 2	2004-03-30
Mouthpiece entrainment airflow control for aerosol generators Grant 6,701,922 - Hindle , et al. March 9, 2	2004-03-09
Method and apparatus for generating an aerosol App 20040016427 - Byron, Peter R. ; et al.	2004-01-29
Mouthpiece entrainment airflow control for aerosol generators App 20030136404 - Hindle, Michael ; et al.	2003-07-24
Method for generating an aerosol App 20020078948 - Hindle, Michael ; et al.	2002-06-27
Delta9 tetrahydrocannabinol (Delta9 THC) solution metered dose inhalers and methods of use App 20020031480 - Peart, Joanne ; et al.	2002-03-14
Pulmonary delivery of pharmaceuticals Grant 6,060,069 - Hill , et al. May 9, 2	2000-05-09
Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent Grant 5,492,688 - Byron , et al. February 20, 1	1996-02-20
Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants Grant 5,202,110 - Dalby , et al. April 13, 1	1993-04-13
Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content Grant 5,190,029 - Byron , et al. March 2, 1	1993-03-02
Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content Grant 5,182,097 - Byron , et al. January 26, 1	1993-01-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.